06/23/2025
3:34 PM | X4 Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/23/2025
7:12 AM | X4 Pharmaceuticals (Filer)
| Form 424B5 | |
06/10/2025
3:25 PM | WYZGA MICHAEL S (Reporting)
X4 Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2025
3:28 PM | MCGIRR DAVID W J (Reporting)
X4 Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/03/2025
5:12 PM | Thoren Natasha Fay (Reporting)
X4 Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
05/20/2025
3:51 PM | Baldry Mark (Reporting)
X4 Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/01/2025
8:22 AM | X4 Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/01/2025
5:25 AM | X4 Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/25/2025
3:44 PM | X4 Pharmaceuticals (Filer)
| Form DEF 14A | |
04/24/2025
7:57 AM | X4 Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/26/2025
5:12 AM | X4 Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
Get the Latest News and Ratings for XFOR and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for X4 Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. |
03/25/2025
6:51 AM | X4 Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/24/2025
3:43 PM | X4 Pharmaceuticals (Filer)
| Form DEF 14A | |
02/06/2025
3:06 PM | X4 Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/31/2025
9:09 AM | VANGUARD GROUP INC (Filed by)
X4 Pharmaceuticals (Subject)
| Form SCHEDULE 13G/A | |
01/27/2025
5:15 PM | Arbet-Engels Christophe (Reporting)
X4 Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/27/2025
5:15 PM | DiBiase Mary (Reporting)
X4 Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/27/2025
5:15 PM | Baldry Mark (Reporting)
X4 Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/27/2025
5:15 PM | Mostafa Adam S. (Reporting)
X4 Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/27/2025
5:15 PM | Ragan Paula (Reporting)
X4 Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2025
3:17 PM | Taveras Arthur (Reporting)
X4 Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/24/2025
3:18 PM | DiBiase Mary (Reporting)
X4 Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/24/2025
3:21 PM | Mostafa Adam S. (Reporting)
X4 Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/24/2025
3:22 PM | Ragan Paula (Reporting)
X4 Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/16/2025
3:45 PM | X4 Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
01/13/2025
6:50 AM | X4 Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/13/2024
8:02 AM | X4 Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/13/2024
7:11 AM | X4 Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/13/2024
5:12 AM | X4 Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/04/2024
1:15 PM | VANGUARD GROUP INC (Filed by)
X4 Pharmaceuticals (Subject)
| Form SC 13G/A | |
10/22/2024
5:06 PM | BlackRock, Inc. (Filed by)
X4 Pharmaceuticals (Subject)
| Form SC 13G | |
10/16/2024
3:54 PM | Ragan Paula (Reporting)
X4 Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/15/2024
3:07 PM | Ragan Paula (Reporting)
X4 Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/08/2024
3:44 PM | Taveras Arthur (Reporting)
X4 Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/08/2024
3:44 PM | DiBiase Mary (Reporting)
X4 Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/08/2024
3:44 PM | Ragan Paula (Reporting)
X4 Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/08/2024
3:44 PM | Baldry Mark (Reporting)
X4 Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/08/2024
3:44 PM | Mostafa Adam S. (Reporting)
X4 Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/04/2024
3:56 PM | X4 Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
09/11/2024
3:01 PM | DiBiase Mary (Reporting)
X4 Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/09/2024
3:28 PM | X4 Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
$100 Trillion “AI Metal” Found in American Ghost Town (Ad) Jeff Brown recently traveled to a ghost town in the middle of an American desert…
To investigate what could be the biggest technology story of this decade.
In short, he believes what he's holding in his hand is the key to the $100 trillion AI boom…
And only one company here in the U.S. can mine this obscure metal. Click here to get the details on this virtual monopoly. |
08/08/2024
5:40 AM | X4 Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/19/2024
7:17 AM | X4 Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
